Clinical effect of Fat-Soluble Vitamin Injection combined with Adenosine Butadionate Methionine in the treatment of alcoholic liver disease with intrahepatic cholestasis
ZHANG Zhi-gang LEI Yuan-feng
Department of Infectious Diseases, Macheng People′s Hospital of Hubei Province, Macheng 438300, China
Abstract：Objective To evaluate the clinical effect of Fat-Soluble Vitamin Injection combined with Adenosine Butadionate Methionine in the treatment of alcoholic liver disease with intrahepatic cholestasis. Methods Clinical data of 126 cases of alcoholic liver disease with intrahepatic cholestasis patients in our hospital during December 2016 to March 2019 were retrospectively analyzed.According to the treatment methods they were divided into control group(68 cases), observation group(58 cases).Patients in control group were treated with Adenosine Butadionate Methionine,those in study group used Fat-Soluble Vitamin Injection combined with Adenosine Butadionate Methionine treatment.Short-term efficacy, liver functionindexes (glutamic oxaloacetic transaminase [AST], alanine aminotransferase [ALT], total bilirubin [TBil], alkaline phosphatase [ALP]), coagulation indexes (prothrombin time [PT], thrombin time [TT], activated partial thromboplastin time [APTT], fibrinogen [FIB]and thromboplastin function [PT]), soluble adhesion molecule-1 (sVCAM-1) and phospholipid transporter (PLTP) were compared between two groups.During treatment period, the incidence of adverse drug reactions were recorded. Results 4 weeks after treatment, the total effective rate in study group was higher than that in control group (χ2=4.645，P=0.031); levels of AST, ALT, TBil and ALP in study group were lower than those in control group (t=15.964, 19.451, 18.656, 9.130，P＜0.05); the PT, TT and APTT in study group were shorer than those in control group, FIB was higher than that in the control group (t=3.334、5.520、4.873、6.704，P＜0.05); levels of sVCAM-1 and PLTP in the control group were lower than those in the control group (t=12.543、6.717, P＜0.05).During treatment, there was no significant difference in the total incidence of adverse drug reactions between two groups (P＞0.05). Conclusion The effect of Fat-Soluble Vitamin Injection combined with Adenosine Butadionate Methionine in patients with alcoholic liver disease and intrahepatic cholestasis is reliable.At the same time, it has good therapeutic safety.
Dong X，Yang H，Li C，et al.Triiodothyronine alleviates alcoholic liver disease injury through the negative regulation of the NLRP3 signaling pathway[J].Exp Ther Med，2018，16（3）：1866-1872.
[2]
Marroni CA，Fleck AM Jr，Fernandes SA，et al.Liver transplantation and alcoholic liver disease：History，controversies，and considerations[J].World J Gastroenterol，2018，24（26）：2785-2805.
[3]
Segovia-Miranda F，Morales-Navarrete H，Kücken M，et al.Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression[J].Nat Med，2019，25（12）：1885-1893.
[6]
Hultin H，Stevens K，SundbomM.Cholecalciferol Injections are effective in hypovitaminosis D after duodenal switch：a randomized controlled study[J].Obes Surg，2018，28（10）：3007-3011.
Curtis K，Anderson C，Seawright A，et al.One hundred fifty liver transplants at a new program in the modern era：the university of mississippi experience[J].Am Surg，2019，85（9）：1025-1027.
[11]
Manley S，Ding W.Role of farnesoid X receptor and bile acids in alcoholic liver disease[J].Acta Pharm Sin B，2015，5（2）：158-167.
[12]
Saeed A，Dullaart RPF，Schreuder TCMA，et al.Disturbed vitamin A metabolism in non-alcoholic fatty liver disease（NAFLD）[J].Nutrients，2017，10（1），pii：E29.
[13]
González-Regueiro JA，Moreno-Castaneda L，Uribe M，et al.The role of bile acids in glucose metabolism and their relation with diabetes[J].Ann Hepatol，2017，16（Suppl 1：s3-105）：16-21.
[14]
Andress EJ，Nicolaou M，McGeoghan F，et al.ABCB4 missense mutations D243A，K435T，G535D，I490T，R545C，and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population[J].Cell Mol Life Sci，2017，74（13）：2513-2524.
[15]
Pérez Fernández V，Ventura S，Tomai P，et al.Determination of target fat-soluble micronutrients in rainbow trout′s muscle and liver tissues by liquid chromatography with diode array-tandem mass spectrometry detection[J].Electrophoresis，2017，38（6）：886-896.
Mangi MA，Rehman H，Minhas AM，et al.Non-alcoholic fatty liver disease association with cardiac arrhythmias[J].Cureus，2017，9（4）：e1165.
[18]
Geys L，Bauters D，Roose E，et al.ADAMTS13 deficiency promotes microthrombosis in a murine model of diet-induced liver steatosis[J].Thromb Haemost，2017，117（1）：19-26.
京公网安备 11010502046607号